Gaxos.ai Inc. (NASDAQ: GXAI) has announced definitive agreements for the immediate exercise of outstanding warrants to purchase up to approximately 3.01 million shares of common stock at a reduced exercise price of $1.20 per share. The transaction is expected to generate approximately $3.6 million in gross proceeds before fees and expenses, with net proceeds intended for working capital and general corporate purposes.
In consideration for the warrant exercise, Gaxos will issue new unregistered warrants to purchase up to approximately 6.02 million shares at an exercise price of $0.95 per share. The offering, for which H.C. Wainwright & Co. is serving as exclusive placement agent, is expected to close on or about Aug. 17, subject to customary closing conditions.
This capital infusion is likely to bolster Gaxos.ai's financial position as it continues to develop its portfolio of AI-powered solutions across defense, health and wellness, entertainment, and productivity. The company aims to make advanced technology more practical and accessible, potentially impacting industries where AI can drive meaningful outcomes.
Investors and industry observers may view this warrant exercise as a sign of confidence in the company's direction, as the reduced exercise price encourages immediate exercise and provides additional funding for operations. The new warrants, with a lower exercise price, could also offer future upside to investors if the stock performs well.
Gaxos.ai is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. Its growing portfolio spans several sectors, bringing intelligent tools to markets where innovation can lead to transformative results.
For more information on the latest news and updates relating to GXAI, visit the company's newsroom at https://ibn.fm/GXAI.
The full press release can be viewed at https://ibn.fm/QpWtV.
